RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis
Open Access
- 23 April 2019
- journal article
- retracted article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 26 (1) , 1-19
Abstract
Cervical cancer is the fourth most frequent cancer in women worldwide and a major cause of mortality in developing countries. Persistent infection with high-risk human papillomavirus (HPV) is a necessary cause for the development of cervical cancer. In addition, genetic and epigenetic alterations in host cell genes are crucial for progression of cervical precancerous lesions to invasive cancer. Although much progress has been made in understanding the life cycle of HPV and it’s role in the development of cervical cancer, there is still a critical need for accurate surveillance strategies and targeted therapeutic options to eradicate these cancers in patients. Given the widespread nature of HPV infection and the type specificity of currently available HPV vaccines, it is crucial that molecular details of the natural history of HPV infection as well as the biological activities of viral oncoproteins be elucidated. A better understanding of the mechanisms involved in oncogenesis can provide novel insights and opportunities for designing effective therapeutic approaches against HPV-associated malignancies. In this review, we briefly summarize epigenetic alterations and events that cause alterations in host genomes inducing cell cycle deregulation, aberrant proliferation and genomic instability contributing to tumorigenesis.Keywords
This publication has 212 references indexed in Scilit:
- Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapesCancer Cell International, 2013
- The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancerBritish Journal of Cancer, 2012
- Regulation of cellular miRNA expression by human papillomavirusesBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2011
- Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regressionVirology, 2011
- Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancersCancer Gene Therapy, 2010
- Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sitesVirology, 2009
- Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-scienceGynecologic Oncology, 2009
- Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoproteinVirology, 2009
- Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB ActivationCancer Cell, 2008
- Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes ApoptosisMolecular Cell, 2007